| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.0000268412.34364.50 |
| P8608 | Fatcat ID | release_azlukgk6jzb7vjv2qxuupihyge |
| P698 | PubMed publication ID | 17463320 |
| P2093 | author name string | Joseph M Metzger | |
| Jennifer Davis | |||
| Haitao Wen | |||
| Terri Edwards | |||
| P433 | issue | 10 | |
| P921 | main subject | restrictive cardiomyopathy | Q2151267 |
| disinhibition | Q5282244 | ||
| P304 | page(s) | 1494-1502 | |
| P577 | publication date | 2007-04-26 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling | |
| P478 | volume | 100 |
| Q30660058 | A Drosophila melanogaster model of diastolic dysfunction and cardiomyopathy based on impaired troponin-T function |
| Q36922076 | A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy |
| Q36743165 | Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants |
| Q33968182 | Analysis of mitochondrial 3D-deformation in cardiomyocytes during active contraction reveals passive structural anisotropy of orthogonal short axes |
| Q36824519 | Analysis of the molecular pathogenesis of cardiomyopathy-causing cTnT mutants I79N, ΔE96, and ΔK210. |
| Q21328674 | Cardiac troponin mutations and restrictive cardiomyopathy |
| Q36260328 | Cardiac-specific deletion of protein phosphatase 1β promotes increased myofilament protein phosphorylation and contractile alterations |
| Q27010320 | Cell biology of sarcomeric protein engineering: disease modeling and therapeutic potential |
| Q41679671 | Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes? |
| Q28472836 | Combinatorial effects of double cardiomyopathy mutant alleles in rodent myocytes: a predictive cellular model of myofilament dysregulation in disease |
| Q33573193 | Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy |
| Q37299072 | Designing heart performance by gene transfer. |
| Q30524974 | Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy. |
| Q34295777 | Disease-related cardiac troponins alter thin filament Ca2+ association and dissociation rates. |
| Q41891917 | Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations |
| Q46731564 | Effect of myofilament Ca(2+) sensitivity on Ca(2+) wave propagation in rat ventricular muscle |
| Q35063399 | Fetal cardiac troponin isoforms rescue the increased Ca2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approach |
| Q42625188 | Functional effects of a restrictive-cardiomyopathy-linked cardiac troponin I mutation (R145W) in transgenic mice |
| Q21129229 | Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: a focused review |
| Q38132253 | Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium |
| Q54979120 | Hypertrophic cardiomyopathy mutations increase myofilament Ca2+ buffering, alter intracellular Ca2+ handling and stimulate Ca2+ dependent signalling. |
| Q37403663 | Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI. |
| Q36077266 | Insights into restrictive cardiomyopathy from clinical and animal studies |
| Q52607493 | Investigation of human iPSC-derived cardiac myocyte functional maturation by single cell traction force microscopy. |
| Q46445601 | Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils. |
| Q33736563 | Molecular determinants of cardiac myocyte performance as conferred by isoform-specific TnI residues |
| Q30481206 | Myosin transducer mutations differentially affect motor function, myofibril structure, and the performance of skeletal and cardiac muscles |
| Q34327056 | Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance |
| Q30498065 | Pathogenic peptide deviations support a model of adaptive evolution of chordate cardiac performance by troponin mutations. |
| Q34107285 | Predicting cardiomyopathic phenotypes by altering Ca2+ affinity of cardiac troponin C. |
| Q28260201 | Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity |
| Q39075815 | Restrictive Cardiomyopathy Caused by Troponin Mutations: Application of Disease Animal Models in Translational Studies |
| Q36984113 | Role of cardiac troponin I carboxy terminal mobile domain and linker sequence in regulating cardiac contraction |
| Q98460845 | Sarcomere integrated biosensor detects myofilament-activating ligands in real time during twitch contractions in live cardiac muscle |
| Q37139625 | Sarcomere neutralization in inherited cardiomyopathy: small-molecule proof-of-concept to correct hyper-Ca2+-sensitive myofilaments |
| Q37159210 | Single histidine button in cardiac troponin I sustains heart performance in response to severe hypercapnic respiratory acidosis in vivo |
| Q36938437 | Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunction. |
| Q30380968 | TNNI1, TNNI2 and TNNI3: Evolution, regulation, and protein structure-function relationships. |
| Q27027023 | Targets for therapy in sarcomeric cardiomyopathies |
| Q27686758 | The cell biology of disease: cellular mechanisms of cardiomyopathy. |
| Q52324907 | TnI Structural Interface with the N-Terminal Lobe of TnC as a Determinant of Cardiac Contractility. |
| Q35866813 | pH-responsive titratable inotropic performance of histidine-modified cardiac troponin I. |
Search more.